ArticleJournal of orthopaedic case reports2026
Intralesional Triamcinolone versus Oral Bisphosphonate for Benign Cystic Bone Lesions: A Prospective Comparative Study of Radiological and Pain Outcomes.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Benign cystic bone lesions, particularly solitary bone cysts and aneurysmal bone cysts, predominantly affect children and adolescents, posing significant orthopedic challenges. Aim: This study was therefore designed to compare intralesional triamcinolone injection and oral bisphosphonate therapy in patients with benign cystic bone lesions, with respect to radiological healing and pain outcomes over a 6-month follow-up period. Materials and Methods: This prospective study enrolled 60 patients with benign cystic bone lesions at the Department of Orthopedics and Trauma Centre, J.A. Group of Hospitals, Gwalior, India. Patients were randomly allocated to Group A (intralesional triamcinolone injection, n = 30) or Group B (oral bisphosphonate, n = 30). Radiological outcomes were assessed using Cole's modification of the Neer grading system, and pain was measured using the Visual Analog Scale (VAS) at baseline, 1, 3, and 6 months. Statistical analyses included the Mann-Whitney U test and McNemar's test. Results: Both groups were comparable at baseline for age, gender, pain duration, and side of involvement. At 6 months, Group A demonstrated significantly superior pain reduction (VAS: 1.48 ± 1.33) compared to Group B (VAS: 5.48 ± 1.50; P < 0.001). Radiological improvement (decrease in Neer grade) occurred in 60% of Group A vs 40% in Group B (P = 0.03). Internal calcification and mineralization were significantly more frequent in Group A (40%) than Group B (16.7%; P = 0.044). Neer-Cole Grade 1 (complete healing) was achieved in 56.67% of Group A versus 23.33% of Group B. Conclusion: Intralesional triamcinolone injection demonstrated superior efficacy compared to oral bisphosphonate in managing benign cystic bone lesions with respect to pain reduction, radiological improvement, and promotion of calcification. Bisphosphonates remain valuable as adjunctive or alternative therapy in specific clinical scenarios. Larger randomized controlled trials with long-term follow-up are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.